Product Information

PIOGLITAZONE HCL 30 MG TABLET is a generic product labeled by Chartwell RX LLC, priced at $0.0903 per EA under NDC 62135080530. Its NADAC has been published 128 times since Mar 13, 2024.

FDA first approved this application on Oct 26, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

PIOGLITAZONE HCL 30 MG TABLET

PIOGLITAZONE HYDROCHLORIDE
$0.0903per EA

Strength

30 mg/1

Manufacturer

Chartwell RX LLC

NDC

62135080530

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

PIOGLITAZONE HYDROCHLORIDE

Approval Type

Generic (ANDA)

FDA Application

ANDA076798

FDA Approved

10/26/2012

TE Code

AB

On Market Since

10/28/2020

Pharmacological Classes

Peroxisome Proliferator Receptor alpha Agonist
Peroxisome Proliferator Receptor gamma Agonist
Peroxisome Proliferator-activated Receptor alpha Agonists
Peroxisome Proliferator-activated Receptor gamma Agonists
Thiazolidinedione
Thiazolidinediones

Price Statistics

The NADAC for PIOGLITAZONE HCL 30 MG TABLET has been published 128 times since Mar 13, 2024, and over the history we have for it it has declined 16.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0903 per EA
All-time high$0.1190 (Apr 10, 2024)
All-time low$0.0828 (Nov 20, 2024)
52-week high$0.0981
52-week low$0.0888
Median price$0.0972
Average price$0.0987
Largest weekly change+24.7% (Jun 19, 2024)
Weeks tracked128
Tracking sinceMar 13, 2024

Price History

1W

+1.7%

1M

+1.7%

3M

-2.3%

6M

-2.9%

1Y

-7.1%

3Y

N/A

5Y

N/A

All

-16.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the PIOGLITAZONE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of PIOGLITAZONE HCL 30 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE HCL 30 MG TABLET, manufactured by Chartwell RX LLC, is $0.0903 per EA (NDC 62135080530), effective Aug 19, 2026.

How has the price of PIOGLITAZONE HCL 30 MG TABLET changed over time?

Over the history we have for it, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has declined 16.6%. It has been tracked across 128 weekly CMS publications since Mar 13, 2024.

What are the highest and lowest recorded NADAC prices for PIOGLITAZONE HCL 30 MG TABLET?

Since Mar 13, 2024, the NADAC for PIOGLITAZONE HCL 30 MG TABLET has ranged from a low of $0.0828 (Nov 20, 2024) to a high of $0.1190 (Apr 10, 2024), with a median of $0.0972 per EA.

Are there cheaper alternatives to PIOGLITAZONE HCL 30 MG TABLET?

No other NADAC-published product currently shares the active ingredient and strength of PIOGLITAZONE HCL 30 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures PIOGLITAZONE HCL 30 MG TABLET?

PIOGLITAZONE HCL 30 MG TABLET (NDC 62135080530) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.